IgNS Podcasts

Join the Conversation

iPlasma and the Future of Donations

iPlasma is an industry technology startup building the future of plasma donor engagement by better connecting plasma centers with millennial and gen z donors. Join this informative discussion about the use of technology and AI in the engagement of donors during this...

read more

Hot Topics in Legal and Regulatory

Join us in a discussion of a variety of legal and regulatory issues that are facing healthcare professionals today. From anti-kickback, the Stark law,  to white- and brown-bagging, this conversation will give you an update on the topics important to us all. Guest: •...

read more

Blurred Lines: Professional Boundaries in the Clinical Setting

Professional boundaries are defined as the spaces between the nurses’ power and the patients’ vulnerability. In all relationships between healthcare professionals and patients, there is an imbalance of power. Healthcare professionals have in-depth access to patients’...

read more

Straight Talk: Experts on COVID-19 Guidance

Join in a conversation with IgNS experts who will discuss the recently updated COVID-19 Resource Guide for Clinicians.  This informative and insightful conversation is designed to help clinicians make sound decisions during these unprecedented times.  With guidance...

read more

Maybe You Should Talk to Someone with Lori Gottlieb

Join us for an interview with Lori Gottlieb, a psychotherapist, author, and columnist, as we explore human connection and mental health in the current environment of pandemic isolation. About the Speaker: Lori Gottlieb is a psychotherapist and author of the New York...

read more

Managing Current Ig Shortages

Immunoglobulin (Ig) is an indispensable therapy used to treat many autoimmune disorders, immunosuppressive disorders, idiopathic diseases, infections, and a myriad of other conditions. Ig is a plasma-derived therapy that originates with a human donor. Production of Ig...

read more
Stay In The Know

Join 45,000+ subscribers and receive important announcements and updates

Subscribe to our mailing list

* indicates required